Drug susceptibility testing results before the start (T0), after 3 months (T3), and at the end of treatment (T8) for patients remaining culture positive at the end of a full treatment course with comparison of RFLP results at T0 and T8.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://figshare.com/articles/dataset/_Drug_susceptibility_testing_results_before_the_start_T0_after_3_months_T3_and_at_the_end_of_treatment_T8_for_patients_remaining_culture_positive_at_the_end_of_a_full_treatment_course_with_comparison_of_RFLP_results_at_T0_and_T8_/545205
下载链接
链接失效反馈官方服务：
资源简介：
Number of patients = 43.
RFLP, Restriction Fragment Length Polymorphism; H, Isoniazid; R, Rifampicin; E, Ethambutol; S, Streptomycin; n/a = not available.
* T0 and T3 isolates identical; T3 and T8 isolates different.
§ Both RFLP profiles were unique.
° Intermediate isolate (T3) showed different RFLP.
** RFLP at T8 not available, but RFLP patterns at T0 and T3 were different.
创建时间：
2013-02-21
